Nextcure Stock Alpha and Beta Analysis
| NXTC Stock | USD 1.19 0.10 7.75% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as NextCure. It also helps investors analyze the systematic and unsystematic risks associated with investing in NextCure over a specified time horizon. Remember, high NextCure's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to NextCure's market risk premium analysis include:
Beta (0.18) | Alpha (0.35) | Risk 3.65 | Sharpe Ratio (0.10) | Expected Return (0.38) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
NextCure |
NextCure Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. NextCure market risk premium is the additional return an investor will receive from holding NextCure long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in NextCure. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate NextCure's performance over market.| α | -0.35 | β | -0.18 |
NextCure expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of NextCure's Buy-and-hold return. Our buy-and-hold chart shows how NextCure performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.NextCure Market Price Analysis
Market price analysis indicators help investors to evaluate how NextCure stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading NextCure shares will generate the highest return on investment. By understating and applying NextCure stock market price indicators, traders can identify NextCure position entry and exit signals to maximize returns.
NextCure Return and Market Media
The median price of NextCure for the period between Tue, Aug 27, 2024 and Mon, Nov 25, 2024 is 1.38 with a coefficient of variation of 6.15. The daily time series for the period is distributed with a sample standard deviation of 0.09, arithmetic mean of 1.39, and mean deviation of 0.06. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | NextCure Presented Results of the Phase 1b Study of NC410 in Combination with Pembrolizumab at ESMO 2024 | 09/16/2024 |
2 | Acquisition by Jones Elaine V of 14250 shares of NextCure at 1.62 subject to Rule 16b-3 | 09/26/2024 |
3 | NextCure to Give Two Presentations at Society for Immunotherapy of CancerAnnual Meeting | 10/04/2024 |
4 | NextCure to Discuss Innovative Cancer Therapies - TipRanks | 11/08/2024 |
5 | Logos Global Management LP Reduces Stake in NextCure Inc | 11/15/2024 |
6 | Acquisition by Feigal Ellen of 14250 shares of NextCure subject to Rule 16b-3 | 11/20/2024 |
About NextCure Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including NextCure or other stocks. Alpha measures the amount that position in NextCure has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2023 | 2024 (projected) | Current Ratio | 34.48 | 17.97 | 16.38 | 15.49 | Net Debt To EBITDA | 0.19 | 0.28 | 0.11 | 0.1 |
NextCure Upcoming Company Events
As portrayed in its financial statements, the presentation of NextCure's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, NextCure's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of NextCure's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of NextCure. Please utilize our Beneish M Score to check the likelihood of NextCure's management manipulating its earnings.
| 7th of March 2024 Upcoming Quarterly Report | View | |
| 2nd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 7th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with NextCure
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out NextCure Backtesting, NextCure Valuation, NextCure Correlation, NextCure Hype Analysis, NextCure Volatility, NextCure History and analyze NextCure Performance. For information on how to trade NextCure Stock refer to our How to Trade NextCure Stock guide.You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
NextCure technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.